Vertebral Fractures Up With Long-Term Delay of Denosumab
Increase in risk with long delay of subsequent doses not significant for composite of all fracture types.
Bone Disorders
Promising Early Results for Use of Teriparatide in the Treatment of Medication-Related Osteonecrosis of the Jaw
This study is the first placebo-controlled clinical trial to investigate a treatment for MRONJ in patients for whom the condition is established.
ASCO Releases Guideline on Addressing Osteoporosis Risk With Nonmetastatic Cancer
The guideline includes strategies to identify patients with nonmetastatic cancer who may be at a higher risk for osteoporotic fractures.
More Than 1 in 4 Middle-Aged Men, Women Have Low Bone Mineral Density
Osteopenia at femoral neck found in 28% of men, 26% of women aged 35 to 50 years
Factors Associated With Bone Erosion Identified in Gout
Investigators evaluated the prevalence, distribution, and factors associated with bone erosion detectable by ultrasound in patients with gout.
Poor Vitamin K Status Linked to Low BMD, Increased Fracture Risk in ESRD
Poor vitamin K status is associated with inflammation and low areal bone mineral density (BMD) among patients with end-stage renal disease.
Senior Cancer Patients Also Benefit From Palliative Radiotherapy
Benefit of palliative radiation for bone metastasis across age groups; older age should not preclude tx.
Osteoporosis Drugs Up Bone Mineral Density in Nonmetastatic PCa
Improvement in BMD was seen with denosumab, which also reduced the incidence of new radiographic vertebral fractures in one high-quality trial.
Total Parathyroidectomy for Refractory SHPT Improves Bone Metabolism
Bone mineral density in the lumbar spine and femoral neck increased over time in hemodialysis patients who underwent total parathyroidectomy without autotransplantation.
Adynamic Bone Disease Prevalent in Type 2 Diabetes Patients With CKD
Almost 40% of pre-dialysis patients with stage 4-5 CKD patients and type 2 diabetes had lab results suggesting low turnover bone disease.
-
Loading...
-
Loading...
